Get the Stockscreener App
114.56
2.07%
-2.425
After Hours:
114.85
0.285
+0.25%
Transmedics Group Inc stock is traded at $114.56, with a volume of 792.76K.
It is down -2.07% in the last 24 hours and down -12.63% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$116.99
Open:
$115.38
24h Volume:
792.76K
Relative Volume:
0.76
Market Cap:
$3.91B
Revenue:
$401.09M
Net Income/Loss:
$32.64M
P/E Ratio:
121.88
EPS:
0.94
Net Cash Flow:
$-120.51M
1W Performance:
+10.15%
1M Performance:
-12.63%
6M Performance:
+70.79%
1Y Performance:
-23.18%
1-Day Range:
$112.50
$116.39
1-Week Range:
$103.65
$119.36
52-Week Range:
$55.00
$169.29
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
114.56 | 3.67B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | Stifel | Hold |
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
Reasons to Retain TransMedics Stock in Your Portfolio for Now - MSN
TransMedics rises after CEO buys company stock - MSN
TransMedics Stock Surge: Investment Opportunity? - StocksToTrade
TransMedics Group (NASDAQ:TMDX) Shares Gap UpHere's What Happened - MarketBeat
TransMedics Group, Inc. $TMDX Stock Position Trimmed by Hsbc Holdings PLC - MarketBeat
Here’s Why Wall Street is Bullish on TransMedics Group (TMDX) - Yahoo Finance
TransMedics Group (NASDAQ:TMDX) Coverage Initiated by Analysts at Stifel Nicolaus - MarketBeat
Comerica Bank Sells 3,047 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term - Yahoo Finance
TransMedics at Morgan Stanley Conference: Ambitious Growth Plans By Investing.com - Investing.com Canada
Transcript : TransMedics Group, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-08-2025 10 - MarketScreener
TransMedics at Morgan Stanley Conference: Ambitious Growth Plans - Investing.com
TransMedics Group (NASDAQ:TMDX) Trading Down 4%Here's What Happened - MarketBeat
First Light Asset Management LLC Decreases Stake in TransMedics Group, Inc. $TMDX - MarketBeat
Braidwell LP Has $57.52 Million Position in TransMedics Group, Inc. $TMDX - MarketBeat
Can TransMedics Group Inc. recover in the next quarter2025 Technical Patterns & Entry and Exit Point Strategies - Newser
Is TransMedics Group Inc. affected by consumer sentimentJuly 2025 Volume & Verified Stock Trade Ideas - خودرو بانک
Northern Trust Corp Buys 7,341 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
What moving averages say about TransMedics Group Inc.July 2025 Technicals & Fast Momentum Stock Entry Tips - Newser
TransMedics Group, Inc. $TMDX Stake Trimmed by Russell Investments Group Ltd. - MarketBeat
Is TransMedics Group Inc. forming a double bottomMarket Sentiment Summary & Target Return Focused Picks - خودرو بانک
Pattern recognition hints at TransMedics Group Inc. upsideJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - Newser
Transmedics Group shares rise 1.15% premarket after Stifel initiates coverage at Neutral. - AInvest
Raymond James Financial Inc. Grows Stock Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
Is TransMedics Group Inc. a candidate for recovery playJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - Newser
Wall Street Zen Downgrades TransMedics Group (NASDAQ:TMDX) to Hold - MarketBeat
Brokerages Set TransMedics Group, Inc. (NASDAQ:TMDX) Price Target at $123.00 - MarketBeat
Assessing TransMedics’ Growth Potential Amid Stifel’s Hold Rating and Strong Q2 Earnings - AInvest
TransMedics stock initiated with Hold at Stifel (TMDX:NASDAQ) - Seeking Alpha
Stifel Initiates Coverage on TransMedics Group with Hold Rating, PT $115 - AInvest
FDA Grants FDA IDE Approval for TransMedics OCS Heart Trial - Medical Product Outsourcing
Is TransMedics Group Inc. vulnerable to short sellers2025 Market WrapUp & Weekly Stock Breakout Alerts - خودرو بانک
Stifel Initiates TransMedics Group at Neutral With $115 Price Target - MarketScreener
Is this a good reentry point in TransMedics Group Inc.2025 Historical Comparison & Weekly Top Gainers Trade List - Newser
Machine Learning Models Forecast TransMedics Group Inc. UptickJuly 2025 Volume & Comprehensive Market Scan Insights - beatles.ru
FORA Capital LLC Has $280,000 Stake in TransMedics Group, Inc. $TMDX - MarketBeat
Driehaus Capital Management LLC Acquires 17,913 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Stifel initiates TransMedics Group stock with Hold rating, $115 target - Investing.com
TransMedics: Just Like The CEO, I'm Buying (NASDAQ:TMDX) - Seeking Alpha
Can trapped investors hope for a rebound in TransMedics Group Inc.Watch List & Real-Time Volume Trigger Notifications - Newser
What machine learning models say about TransMedics Group Inc.Weekly Trend Report & AI Driven Stock Price Forecasts - Newser
Applying sector rotation models to TransMedics Group Inc.IPO Watch & Free Growth Oriented Trading Recommendations - Newser
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):